Реперфузионная терапия при ишемическом инсульте в Российской Федерации: проблемы и перспективы

摘要: Current technologies for treating ischemic stroke (IS) within the first 4.5 hours after its onset involve highly effective brain substance reperfusion techniques (thrombolytic therapy (TLT)) aimed at restoring blood flow in affected vessel. There has been a substantial increase number of systemic TLT procedures establishing subdivisions as part regional vascular centers and primary departments our country. In past 5 years, IS patients undergoing thrombolysis virtually risen 10-fold. 2009–2013, Russian Federation performed 10,718 mainly with moderate stroke. The further is hindered by fact that they seek medical advice too late acute cerebrovascular attack (ACVA) because population low knowledge (therefore education campaigns are so important to awareness signs ACVA), prehospital delays problems, poor organization hospital admission (delays diagnostic procedures). It should be admitted specialized ACVA soon possible. According AHA/ASA guidelines, time between initiation (door-to-needle time) not exceed 60 minutes. major factors influencing door-to-needle follows: neurological examination, neuroimaging results, examination necessary laboratory findings, transfer an intensive care unit computed tomography. One may identify following quality indices (necessary diagnostic, therapeutic, other interventions), which negatively affect safety efficiency TLT: errors determining contraindications reperfusion, noncompliance protocol thrombolysis, patient monitoring. terms available potential established departments, it absolutely real through active information among population, will contribute earliest also make organizational improvements healthcare system all stages.